ClinicalTrials.gg
RecruitingNCT07875075usgUpdated Oct 15, 2026

Core Muscle Function and Postural Control in Lower Extremity Amputees

An observational study in Amputation, Ultrasonography and Postural Control, sponsored by Hacettepe University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 20 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by Hacettepe University · Observational

From the registry’s dates

  • Started Dec 2025; still recruiting 10 months later.
Updated Oct 15, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
32
Ages
20 Years to 60 Years
Sex
All
01

Study summary

The primary aim of this study is to determine the effect of amputation on core muscle groups by comparing core muscle thickness in individuals with lower extremity amputation to both their intact side and a healthy control group using ultrasonographic assessment.

The secondary aim is to investigate the relationship between core muscle thickness and postural stability outcomes during different activities in individuals with lower extremity amputation, and to determine the effect of core muscles on postural control.

Read the detailed description

This study aims to investigate the effects of lower extremity amputation on core muscles and their relationship with postural control. The primary objective is to compare core muscle thickness in individuals with lower extremity amputation with both their intact side and a healthy control group using ultrasonographic assessment. The secondary objective is to examine the relationship between core muscle thickness and postural stability during different functional activities, and to determine the role of core muscles in postural control.

It is hypothesized that there are differences in core muscle thickness between the amputated and intact sides, as well as between amputees and healthy individuals. Additionally, core muscle function is expected to be associated with postural sway, limits of stability, functional tasks (such as sit-to-stand and stair negotiation), prosthesis adaptation, fear of falling, and the percentage of limb loss.

The study sample will consist of transtibial and transfemoral amputees who attend routine follow-up visits, along with a matched healthy control group. Ultrasonography will be used to objectively assess core muscle thickness, allowing the identification of muscle atrophy and asymmetrical loading. Postural control will be evaluated using a computerized balance system during various activities.

Statistical analyses will include descriptive statistics, normality tests, group comparisons, and correlation analyses. The findings are expected to contribute to the development of targeted rehabilitation programs focusing on core muscles to improve postural stability and reduce fall risk in individuals with lower extremity amputation.

02

Conditions studied

  • Amputation
  • Ultrasonography
  • Postural Control
  • Balance
  • Core Muscles
  • Stiffness

Keywords

  • amputation
  • ultrasonography
  • balance
  • limits of stability
  • stiffness
03

In context

Lead sponsor

Hacettepe University is the lead sponsor of 1,001 studies on the registry; 215 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Amputees who applied to our faculty for prosthesis construction and control, and healthy individuals from relatives of the researcher reached by snowball method will constitute the sample of the study.

Eligibility criteria

For the Amputee Group

Inclusion Criteria:

  • Being between 20-60 years of age
  • Having a unilateral transtibial or transfemoral amputation
  • Being at K1-K3 functional activity level
  • Being able to stand without the use of assistive devices
  • Using a prosthesis for at least 4 hours per day
  • Volunteering to participate in the study

Exclusion Criteria:

  • Having phantom or residual limb pain ≥6 according to the Numeric Rating Scale
  • Having bilateral lower extremity amputation
  • Having a Body Mass Index greater than 30

For the Healthy Control Group

Inclusion Criteria:

  • Healthy individuals with demographic characteristics similar to the amputee group
  • Not having a regular exercise habit

Exclusion Criteria:

  • Having central or peripheral vestibular disorders
  • Having lower extremity joint contractures
  • Using medications that affect balance
  • Having a Body Mass Index greater than 30
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
32 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • 1) Experimental Group: individual with amputation

    Participants in the amputee group will include individuals aged 20-60 years with unilateral transtibial or transfemoral amputation, classified as K1-K3 functional level, who are able to stand without assistive devices and use their prosthesis for at least 4 hours per day. All participants must provide voluntary informed consent. Individuals will be excluded if they have severe phantom or residual limb pain (≥6 on the Numeric Rating Scale), bilateral lower extremity amputation, or a body mass index greater than 30.

  • Control Group: Healthy Subjects

    The control group will consist of healthy individuals with demographic characteristics similar to the amputee group and without a regular exercise habit. Individuals will be excluded if they have central or peripheral vestibular disorders, lower extremity joint contractures, use medications affecting balance, or have a body mass index greater than 30.

06

What researchers measure

Primary outcomes

  1. Diaphragm Thickening Fraction

    Diaphragm thickness will be assessed bilaterally at the zone of apposition using B-mode ultrasonography at the end of quiet expiration and during deep inspiration. Diaphragm thickening fraction will be calculated as \[(thickness during deep inspiration - thickness at the end of quiet expiration) / thickness at the end of quiet expiration\] × 100 and reported as a percentage (%). Three high-quality measurements will be obtained for each side, and the mean value will be used for analysis. Bilateral measurements will be used for side and group comparisons.

    Time frame: Day 1

  2. Transversus Abdominis Activation Ratio

    Transversus abdominis muscle thickness will be assessed bilaterally using B-mode ultrasonography at the end of quiet expiration at rest and during the abdominal drawing-in maneuver. The activation ratio will be calculated by dividing muscle thickness during the abdominal drawing-in maneuver by muscle thickness at rest. Three high-quality measurements will be obtained for each side, and the mean value will be used for analysis. The activation ratio is dimensionless. Bilateral measurements will be used for side and group comparisons.

    Time frame: Day 1

  3. Internal Oblique Activation Ratio

    Internal oblique muscle thickness will be assessed bilaterally using B-mode ultrasonography at the end of quiet expiration at rest and during the abdominal drawing-in maneuver. The activation ratio will be calculated by dividing muscle thickness during the abdominal drawing-in maneuver by muscle thickness at rest. Three high-quality measurements will be obtained for each side, and the mean value will be used for analysis. The activation ratio is dimensionless. Bilateral measurements will be used for side and group comparisons.

    Time frame: Day 1

Secondary outcomes

  1. Standing Postural Sway

    Standing postural sway will be assessed using the Modified Clinical Test of Sensory Interaction on Balance (mCTSIB) with the NeuroCom Balance Master. Center-of-gravity sway velocity will be measured during standing under four sensory conditions: eyes open on a firm surface, eyes closed on a firm surface, eyes open on a foam surface, and eyes closed on a foam surface. Sway velocity will be expressed in degrees per second (°/s), with lower values indicating better postural stability.

    Time frame: Day 1

  2. Percentage of Remaining Limb

    The remaining limb length will be measured using a tape measure. The percentage of remaining limb will be calculated by dividing the remaining limb length by the total lower-extremity length and multiplying by 100. The result will be expressed as a percentage (%).

    Time frame: Day 1

  3. Prosthesis Awareness

    Prosthesis awareness will be assessed using the amputee-adapted Forgotten Joint Score-12 (FJS-12). The questionnaire consists of 12 items evaluating awareness of the prosthesis during activities of daily living. Higher scores indicate a greater ability to forget the prosthesis during daily activities.

    Time frame: Day 1

  4. Fear of Falling

    Fear of falling will be assessed using the Falls Efficacy Scale-International (FES-I). The scale consists of 16 items scored from 1 to 4, with a total score ranging from 16 to 64. Higher scores indicate greater concern about falling.

    Time frame: Day 1

  5. Reaction Time During Limits of Stability Test

    Reaction Time During Limits of Stability Test Reaction time will be assessed using the Limits of Stability test of the NeuroCom Balance Master. It represents the time between the visual cue and the initiation of voluntary movement toward the target and will be reported in seconds (s).

    Time frame: Day 1

  6. Movement Velocity During Limits of Stability Test

    Movement velocity will be assessed using the Limits of Stability test of the NeuroCom Balance Master. It represents the average speed of center-of-gravity movement toward the target and will be reported in degrees per second (°/s).

    Time frame: Day 1

  7. Endpoint Excursion During Limits of Stability Test

    Endpoint excursion will be assessed using the Limits of Stability test of the NeuroCom Balance Master. It represents the distance reached by the center of gravity during the initial movement toward the target and will be reported as a percentage (%).

    Time frame: Day 1

  8. Maximum Excursion During Limits of Stability Test

    Maximum excursion will be assessed using the Limits of Stability test of the NeuroCom Balance Master. It represents the maximum distance reached by the center of gravity toward the target and will be reported as a percentage (%).

    Time frame: Day 1

  9. Directional Control During Limits of Stability Test

    Directional control will be assessed using the Limits of Stability test of the NeuroCom Balance Master. It reflects the accuracy of center-of-gravity movement toward the intended target relative to extraneous movement and will be reported as a percentage (%).

    Time frame: Day 1

  10. Weight Transfer Time During Sit-to-Stand

    Weight transfer time will be assessed using the Sit-to-Stand test of the NeuroCom Balance Master. It represents the time from the initiation of the test until the center of gravity is transferred over the feet and will be reported in seconds (s).

    Time frame: Day 1

  11. Rising Index During Sit-to-Stand

    The rising index will be assessed using the Sit-to-Stand test on the NeuroCom Balance Master. It represents the force exerted by the lower extremities on the force platform during rising, normalized to body weight, and will be reported as a percentage (%).

    Time frame: Day 1

  12. Postural Sway Velocity After Sit-to-Stand

    Postural sway velocity will be assessed using the Sit-to-Stand test on the NeuroCom Balance Master. It represents the center-of-gravity sway velocity during the first five seconds after rising to a standing position and will be reported in degrees per second (°/s).

    Time frame: Day 1

  13. Weight-Bearing Asymmetry During Sit-to-Stand

    Weight-bearing asymmetry will be assessed using the Sit-to-Stand test on the NeuroCom Balance Master. It quantifies the asymmetry in load distribution between the right and left lower extremities during the sit-to-stand task and in the first five seconds of standing, and will be reported as a percentage (%).

    Time frame: day 1

  14. Lift-Up Index During the Step Up/Over Task

    The lift-up index will be assessed using the Step Up/Over test on the NeuroCom Balance Master. It represents the force exerted by the stepping limb to raise the body onto the step, normalized to body weight, and will be reported as a percentage (%).

    Time frame: Day 1

  15. Movement Time During the Step Up/Over Task

    Movement time will be assessed using the Step Up/Over test on the NeuroCom Balance Master. It represents the time required to complete the stepping movement and will be reported in seconds (s).

    Time frame: day 1

  16. Impact Index During the Step Up/Over Task

    The impact index will be assessed using the Step Up/Over test on the NeuroCom Balance Master. It represents the force exerted on the force platform during landing, normalized to body weight, and will be reported as a percentage (%).

    Time frame: Day 1

07

Study locations

1 of 1 sites recruiting
  • Dokuz Eylül University Faculty of Physical Therapy and Rehabilitation 15 July Health Campus, Mithatpaşa Street No: 56/15 İnciraltı 35340 - İZMİR
    Balçova, İzmir 35130, Turkey (Türkiye)
    Recruiting
08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07875075
Responsible party
Gökhan Karakaş (Principal Investigator, Hacettepe University) — Principal investigator
First posted
Oct 15, 2026
Start date
Dec 4, 2025
Primary completion
Jul 4, 2027 (estimated)
Completion
Dec 4, 2027 (estimated)
Last update
Oct 15, 2026

Study contacts

Seher Özyürek, Prof.
Contact
seherozyurek@gmail.com
0 232 4124935

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion